1. Pages:
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7
  9. 8
  10. ...
  11. 15

Essay on Bilski: Patent Claim Scope
October 22nd, 2010

What does Bilski portend for the future of patent law?  What was the real concern of the Justices in Bilski?  Was it with the undue breadth of the claims in question, claims that the Justices intuitively felt went beyond a “new and useful” contribution?   Does the majority holding Bilski suggest a shift away from the formalistic Section 101 categories of patent eligible subject matter, such as the definition of “process” and the judicial exceptions for “abstract ideas,” and toward the traditional fact-based regulators of patent claim scope, such as enablement, novelty and unobviousness?

Chisum explores these questions in a work in progress: “Weeds and Seeds in the Supreme Court’s Business Method Patents Decision: New Directions for Regulating Patent Scope.”  Essay on Bilski

Notes on Bilski
June 29th, 2010

On June 28, 2010, the Supreme Court decided the Bilski decision.  Here is a pdf version: .Bilski   A commentary is being prepared.   A brief preliminary summary:

Read the rest of this entry »

CPLRG™ 0015 - Bilski v. Kappos - Jun. 28, 2010

Bilski v. Kappos, 130 S. Ct. 3218, CPLRG 0015 (2010) (KENNEDY, Roberts, Thomas, Alito & Scalia (except for Parts II-B-2 and II-C-2), STEVENS, Ginsburg, Breyer & Sotomayor, concurring; BREYER & Scalia (as to Part II), concurring)   

BilskiUSSCt06282010

MAJOR ISSUES: Business method patents; “process” in Section 101; exceptions for abstract ideas, natural phenomena, and laws of nature Read CPLRG™ 0015

CPLRG™ 0075 - Patent Rights Protection Group, LLC v. Video Gaming Technologies, Inc. - May. 12, 2010

Patent Rights Protection Group, LLC v. Video Gaming Technologies, Inc., 603 F.3d 1364 (Fed. Cir. 2010) (LINN, Rader & Archer) PatentRightsProtectionGroup05122010

Major Issues:  personal jurisdiction; trade show attendance; reasonableness of exercise of jurisdiction; suits against multiple accused infringers; jurisdictional discovery; 2011 Supreme Court decisions, J. McIntyre, Goodyear Read CPLRG™ 0075

CPLRG™ 0065 - Ortho-McNeil Pharmaceutical, Inc. v. Lupin Pharmaceuticals, Inc. - May. 10, 2010

Ortho-McNeil Pharmaceutical, Inc. v. Lupin Pharmaceuticals, Inc., 603 F.3d 1377, CPLRG 0065 (Fed. Cir. 2010) (NEWMAN, Rader & Linn) OrthoLupin05102010

MAJOR ISSUES: patent term extension for drugs, Hatch-Waxman Act; first commercial marketing of “drug product”; active ingredient of drug product; enantiomer distinct from racemate Read CPLRG™ 0065

  1. Pages:
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7
  9. 8
  10. ...
  11. 15

©2010 Donald S. Chisum - All Rights Reserved

Website design by Bluegrass Internet Services